Cagrilintide (5mg) – Next-Generation Amylin Analogue for Advanced Metabolic Research

Are you looking to unlock revolutionary breakthroughs in metabolic, obesity, and glycemic regulation studies? Cagrilintide represents the vanguard of modern peptide research. As a long-acting, non-selective amylin receptor agonist, this cutting-edge investigational compound offers researchers an extraordinary opportunity to explore non-GLP-1 pathways in appetite suppression, energy expenditure, and weight modulation.

When paired in co-formulation studies or analyzed as a monotherapy, Cagrilintide consistently demonstrates unmatched potential in reducing caloric intake and optimizing metabolic markers.

What is Cagrilintide?

Cagrilintide is an novel, acylated, long-acting analogue of human amylin—a peptide hormone naturally co-secreted with insulin by pancreatic beta cells. While traditional metabolic research has heavily focused on Glucagon-Like Peptide-1 (GLP-1) receptor agonists, Cagrilintide targets a distinct physiological mechanism.

By activating human amylin receptors (AMYR1, AMYR2, and AMYR3) alongside calcitonin receptors (CTR), Cagrilintide induces potent homeostatic satiety signals directly within the central nervous system. Its engineered lipophilic side-chain enables a significantly extended half-life, making it an exceptional candidate for once-weekly laboratory protocols.

Mechanism of Action: The Power of Amylin Agonism

Unlike standard GLP-1 receptor agonists that primarily slow gastric emptying and enhance glucose-dependent insulin secretion, amylin analogues target the brain’s satiety centers in the area postrema and hypothalamus.

• Satiety Induction: Suppresses signal pathways responsible for hunger and food-seeking behavior.

• Delayed Gastric Emptying: Prolongs postprandial fullness without causing abrupt glucose spikes.

• Glucagon Suppression: Inhibits inappropriate post-meal glucagon secretion, stabilizing ambient glucose levels.

Key Benefits of Cagrilintide in Research Models

1. Exceptional Synergistic Weight Management

While Cagrilintide demonstrates significant efficacy as a standalone compound, ongoing preclinical and clinical literature highlights its unmatched performance when combined with GLP-1 receptor agonists (such as Semaglutide). The dual-targeting strategy (Amylin + GLP-1) creates a complimentary neuro-endocrine effect, driving unprecedented weight loss results in experimental models.

2. Enhanced Glycemic Control

By modulating postprandial glucagon release and slowing nutrient absorption into circulation, Cagrilintide provides a multi-faceted approach to studying insulin resistance, Type 2 Diabetes, and metabolic syndrome.

3. Optimized Body Composition

Experimental data indicates that satiety induced via amylin receptor activation helps lower overall body fat mass while preserving lean muscle mass during caloric restriction phases—a vital metric for long-term metabolic health research.

Product Specifications

• Sequence: Acylated Human Amylin Analogue

• Purity: ≥ 98% (Verified by HPLC & Mass Spectrometry)

• Form: Lyophilized Powder

• Storage: Store at -20°C (Stable at room temperature during shipping)

• Reconstitution: Reconstitute using Bacteriostatic Water or Sterile Saline

Why Source Your Research Peptides From Us?

When conducting critical metabolic research, purity, stability, and consistency are non-negotiable. Our Cagrilintide undergoes rigorous third-party testing to guarantee exact concentration, zero fillers, and high bioactivity in every vial.

• Third-Party Certificate of Analysis (CoA): Verified purity for every batch.

• Rapid, Temperature-Controlled Shipping: Ensures peptide integrity upon delivery.

• Premium Lyophilization: Preserves long-term molecular stability.

Frequently Asked Questions (FAQ)

How does Cagrilintide differ from GLP-1 receptor agonists?

Cagrilintide is an amylin receptor agonist, not a GLP-1 receptor agonist. While GLP-1 agonists target the GLP-1 receptor to regulate glucose and appetite, Cagrilintide targets calcitonin and amylin receptors. Utilizing both pathways simultaneously yields a distinct, additive metabolic effect.

How should lyophilized Cagrilintide be stored?

Store sealed vials in a freezer at -20°C for long-term stability. Once reconstituted with a suitable solvent, keep the solution refrigerated between 2°C to 8°C and use within the recommended laboratory protocol window.

Disclaimer: This product is sold strictly for laboratory research, analytical, and educational purposes. It is not intended for human consumption, medical diagnosis, therapeutic use, or veterinary applications.